Case File
efta-efta02113372DOJ Data Set 10CorrespondenceEFTA Document EFTA02113372
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-efta02113372
Pages
0
Persons
0
Integrity
No Hash Available
Loading PDF viewer...
Extracted Text (OCR)
EFTA DisclosureText extracted via OCR from the original document. May contain errors from the scanning process.
T:
Cc:
a
From:
Joseph Thakuria
Sent
Sat 3/1/2014 7:41:42 PM
Subject Re: Jeffrey Epstein
Hi Richard, my study is still awaiting irb approval at mgh. Once that goes through, there'll be a
consent form for Jeffrey to review and sign and then I can forward the invoice from Illumina for
the rapid turn-around-time whole genome.
Once we have his data and go through the analyses Illumina provides, I can discuss with him any
extra value from using additional tools for analyses.
The irb approval process will take 3-5 weeks in the best case scenario. As a physician, I could just
order it for him from Illumina but Jeffrey and I agreed the research route made the most sense.
For one, ordering a whole genome on a (presumably) healthy patient is not currently indicated.
Doing this as a patient (at least at mgh) would also entail creating a medical record of the
encounter and the results. Our plan is to keep this data private - at least until he's had a chance to
review with me. So, for this reason, we also agreed to go the "research study" route with his
genome.
I've discussed doing Jeffrey's genome through my mgh study with gcorge church and he's fine
with it. I'll coordinate getting JE's samples from the pgp and moving all of it, or a portion
(aliquots of the dna and cell lines) to the new study (again, after the mgh study is formally
approved - that's the bottleneck now).
with Jeffrey not on the cc, please pass the info above on to him. Let me know if he has
any questions. I can clarify anything by email or phone.
Maybe there was a misunderstanding when I mentioned the 'rapid turnaround time' offering from
illumina? This just means illumina's role - the sequencing of the sample - is expedited. There is no
way, unfortunately, to expedite the MGH IRB process for approving human research studies. (A
lot of us wish there was!)
Joe Thakuria
Joseph V. Thakuria, MD, MMSc
Medical Genetics and Metabolism Attending Physician
Director, MGH Stickler Syndrome Program
Harvard Catalyst CRC Protocol Review Committee
Massachusetts General H
ital
185 Cambridge St.,
B
n MA 02115
EFT/_R1_00738911
EFTA02113372
Jeffrey has approved the 11,400
Please send me an invoice so work can begin immediately
Thank you
Richard Kahn
HBRK Associates Inc.
575 Lexington Avenue, 4th Floor,
New York, New York 10022
On Feb 21, 2014, at 6:34 PM
wrote:
> Hello Joe. I have Jeffrey's accountant on this email as well, Rich Kahn . Jeffrey has told Rich he
would like to do a $5000 genetic work up done for the time being. Could you coordinate with
Rich regarding payment/next steps?
> Thank you,
> Assistant to Jeffrey Epstein
> Sent from my iPhone
EFTA_R1_00738912
EFTA02113373
Related Documents (6)
DOJ Data Set 10CorrespondenceUnknown
EFTA Document EFTA02100786
0p
DOJ Data Set 10OtherUnknown
EFTA02113115
2p
DOJ Data Set 10CorrespondenceUnknown
EFTA Document EFTA02103715
0p
DOJ Data Set 10OtherUnknown
EFTA02103263
3p
DOJ Data Set 10OtherUnknown
EFTA02117612
5p
DOJ Data Set 10CorrespondenceUnknown
EFTA Document EFTA02103883
0p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.